Companies: 10,795·Total market cap: $144.5T
PMV Pharmaceuticals, Inc.

PMV Pharmaceuticals, Inc.

PMVPNASDAQHealthcare● Active
$1.09
$-0.03(-2.68%)
Market Cap$58131625
P/E Ratio
52W High$1.88
52W Low$0.964
Overview

PMV Pharmaceuticals, Inc. (PMVP) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · PMVP · as of Jun 9, 2026

Key Statistics

EPS (TTM)$-1.49pmvp eps ttm · pmvp earnings per shareEarnings history
PE Ratio (TTM)pmvp pe ratio ttm · pmvp price to earningsPE Ratio deep dive
Revenue (TTM)0.00pmvp revenue ttm · pmvp annual revenueFull revenue history
Dividend YieldNo Dividenddoes pmvp pay dividends · pmvp dividend yieldDividend history
Shares Outstanding52.5Mpmvp shares outstanding · pmvp floatShares outstanding history
Next EarningsAug 6, 2026Est.pmvp earnings date · pmvp next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$0.00
202320242025
pmv pharmaceuticals, inc. revenue · pmvp revenue 2025
FY 2025Net Income-$77.7M▼ 32.42% YoY
202320242025
pmv pharmaceuticals, inc. net income · pmvp profit 2025
FY 2025EPS$-1.48▼ 30.03% YoY
202320242025
pmvp eps · pmv pharmaceuticals, inc. earnings per share 2025
TTM:Revenue: $0.00Net Income: -$78.3MEPS: $-1.49View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy4 analystsis pmvp a buy · pmvp analyst rating
Strong Buy
0
Buy
4
Hold
0
Sell
0
Strong Sell
0
12-Month Price Target
$5.00Low
$1.09Current
$5.00Avg Target358.72% upside
$5.00High
pmvp price target · pmvp 12 month forecast

Total: 4 · Buy rate: 100.0%

The PMVP analyst consensus is Buy, based on ratings from 4 Wall Street analysts over the past 3 months. The average 12-month price target is $5.00, representing +358.72% upside from the current price of $1.09.

Stock Performance

Full History
1D-2.68%
1W-7.63%
1M-22.70%
3M-33.54%
YTD-12.80%
1Y+2.83%
5Y-96.72%

About PMV Pharmaceuticals, Inc.

CEODavid H. Mack
IPO DateSep 25, 2020
Employees47
CountryUS

PMV Pharmaceuticals, Inc. operates as a precision oncology company focused on discovering and developing both small molecule and tumor-agnostic therapies to address p53 mutations in cancer patients. T…

what is pmv pharmaceuticals, inc. · pmvp stock overview · pmv pharmaceuticals, inc. company profile · who is pmv pharmaceuticals, inc. ceo · pmvp NASDAQ · pmv pharmaceuticals, inc. headquarters · pmv pharmaceuticals, inc. business segments

About Stock Overview & Key Data

PMV Pharmaceuticals, Inc. (PMVP) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Sep 25, 2020. As of the latest trading session, PMVP stock price is $1.09, with a market capitalization of $58.1M. The stock has returned +2.83% over the past 12 months and -12.80% year-to-date.

According to 4 Wall Street analysts, the consensus rating for PMV Pharmaceuticals, Inc. stock is Buy, with an average 12-month price target of $5.00. In fiscal year 2025, PMV Pharmaceuticals, Inc. reported revenue of — and net income of -$77.7M. For detailed data — including PMV Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, PMV Pharmaceuticals, Inc. (PMVP) stock price is $1.09. The stock is traded on NASDAQ under the ticker symbol PMVP. The 52-week range is $0.96 – $1.88.

PMVP stock pricePMVP quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice